New Delhi: A drug used to treat asthma and allergies can reduce replication of SARS-COV-2 in human immune cells by blocking a crucial protein produced by the virus, according to a study by researchers at the Indian Institute of Science (IISc) – Bengaluru. The drug, called montelukast, is approved by the US Food and Drug Administration […]
